Skip to content

13F-HR filed by Aquilo Capital Management, LLC

Aquilo Capital Management, LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 13 holding rows worth $180,452,120.

Accession
0001591986-23-000007
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 13 entries on the cover page, a total value of $180,452,120 stated on the cover page (in dollars after the unit check, H1), rows summing to $180,452,120 with VALUE read as dollars as filed, 13F file number 028-18892. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ARROWHEAD PHARMACEUTICALS IN04280A100COM858,474$30,613,183dollars as filed
BLUEPRINT MEDICINES CORP09627Y109COM448,987$28,375,978dollars as filed
iShares Russell 2000 ETF464287655SHS150,000$28,090,500dollars as filedput
MERUS N VN5749R100COM775,109$20,408,620dollars as filed
REGENXBIO INC75901B107COM870,114$17,393,579dollars as filed
ARVINAS INC04335A105COM623,941$15,486,216dollars as filed
KYMERA THERAPEUTICS INC501575104COM651,325$14,973,962dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS1,312,233$7,217,282dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share174,648$6,638,370dollars as filed
ARGENX SE SPONSORED ADR04016X101ADR16,315$6,358,445dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM250,000$2,257,500dollars as filed
C4 THERAPEUTICS INC12529R107COM STK760,657$2,091,807dollars as filed
PIERIS PHARMACEUTICALS INC720795103COM3,303,190$546,678dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001591986-23-000007this filing2023-08-14acceptance time not in the bulk data set